1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc XNAS: IBRX
6.42 -0.06 (-0.93%)
61.3M

XNAS 21 Jan, 2026 12:46 PM (EST)

Watchlist

Portfolio

Alert

Regulatory Tailwinds
ImmunityBio rises on Tuesday as FDA clears approval path for its bladder cancer drug, ANKTIVA See details